ask="5.190"
ask_size="500"
average_daily_volume="34019"
bid="5.100"
bid_size="400"
book_value="1.278"
change="+0.249"
change_from_200_day_moving_average="1.267"
change_from_50_day_moving_average="0.970"
change_from_52_week_high="-2.521"
change_From_52_week_low="2.419"
change_in_percent="+5.030%"
close="5.199"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.381"
ebitda="-15.34M"
eps_estimate_current_year="-1.390"
eps_estimate_next_quarter="-0.300"
eps_estimate_next_year="-1.170"
ex_dividend_date="N/A"
float_shares="6708000"
high="5.236"
high_52_weeks="7.720"
last_trade_date="2/28/2017"
last_trade_price="5.199"
last_trade_size="400"
last_trade_time="3:59pm"
low="4.500"
low_52_weeks="2.780"
market_capitalization="63.16M"
moving_average_200_day="3.932"
moving_average_50_day="4.229"
name="Galmed Pharmaceuticals Ltd."
notes="N/A"
one_year_target_price="13.400"
open="4.990"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+32.215%"
percent_change_from_50_day_moving_average="+22.951%"
percent_change_from_52_week_high="-32.655%"
percent_change_from_52_week_low="+87.014%"
previous_close="4.950"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.873"
price_per_sales="311.594"
revenue="193000.00"
shares_outstanding="12149000"
short_ratio="3.920"
stock_exchange="NCM"
symbol="GLMD"
volume="158720"
weeks_range_52="2.780 - 7.720"
